The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract

APMIS

Volumn 108, Issue 6, 2000, Pages 467-472

  Tot, Tibor ^a  

^a FALUN HOSPITAL   (Sweden)

Author keywords

Cytokeratin 20; Cytokeratin 7; Estrogen receptor; Lobular breast cancer; Signet ring cell carcinoma

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; ESTROGEN RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; SIGNET RING CARCINOMA;

EID: 0033846360     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-84.x     Document Type: Article

References (34)

1. Metastases of undetermined source
2. Treatment of patients with cancer of unknown primary site
3. Metastatic adenocarcinoma of unknown primary origin
4. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas
5. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas
6. Keratin 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary
7. Cytokeratin 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma
8. Adenocarcinomas metastatic to the liver: The value of cytokeratins 20 and 7 in the search for unknown primary tumors
9. Primary adenocarcinoma of the urinary bladder: A clinicopathologic analysis of 72 cases
10. Signet ring cell carcinoma of the prostate
11. Signet-ring-cell thyroid tumors. Follicle cell tumors with arrest of folliculogenesis
12. Pleomorphic lobular carcinomas of the breast: An aggressive tumor showing apocrine differentiation
13. Lobular carcinoma of the breast: A special variant of mucin-secreting carcinoma
14. The significance of signet ring cells in infiltrating lobular carcinomas of the breast
15. Signet ring cell lymphoma. A rare morphologic and functional expression of nodular (follicular) lymphoma
16. T-cell signet ring cell lymphoma
17. Signet ring cell melanoma. A rare morphologic variant of malignant melanoma
18. Mucicarminophilic histiocytosis. A polyvinylpyrrolidone (PVP) storage disease simulating signet-ring cell carcinoma
19. Mucicarminophilic histiocytosis (benign signet ring cells) and hyperplastic mesothelial cells. Two mimics of metastatic carcinoma within a single lymph node
20. Signet ring cell stromal tumor of ovary: Immunohistochemical light and electron microscopic study
21. Gastrointestinal stromal tumors with prominent signet ring cell features
22. Cytokeratin 20 in human carcinomas
23. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns
24. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas
25. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootless
26. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites
27. Primary versus metastatic pulmonary adenocarcinoma: An immunohisto- chemical study using villin, cytokeratin 7 and 20
28. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites
29. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma
30. Utility of CK20 in identifying the origin of metastatic carcinomas in effusions
31. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns
32. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung
33. Metastatic breast cancer to the stomach: Immunohistochemistry in breast cancer prognosis and prediction